HLB Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2019	FY 2018	FY 2017
Period Ending	Oct '25 Oct 30, 2025	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Market Capitalization	215,830	75,194	58,507	80,206
Market Cap Growth	-41.11%	28.52%	-27.05%	-
Enterprise Value	203,482	77,595	62,071	-
Last Close Price	15370.00	5430.00	4225.00	6420.00
PE Ratio	456.63	159.09	-	-
PS Ratio	5.98	2.08	2.85	5.16
PB Ratio	12.06	4.20	3.44	4.77
P/TBV Ratio	12.36	4.31	3.50	4.83
P/OCF Ratio	159.48	55.56	-	-
EV/Sales Ratio	5.64	2.15	3.02	-
EV/EBITDA Ratio	66.05	25.19	-	-
EV/EBIT Ratio	141.22	53.85	-	-
Debt / Equity Ratio	0.74	0.74	0.45	0.89
Debt / EBITDA Ratio	4.28	4.28	-	-
Asset Turnover	0.88	0.88	0.54	-
Inventory Turnover	3.27	3.27	3.13	-
Quick Ratio	1.01	1.01	0.94	1.01
Current Ratio	1.26	1.26	1.31	1.31
Return on Equity (ROE)	2.71%	2.71%	-41.77%	-
Return on Assets (ROA)	2.19%	2.19%	-9.55%	-
Return on Capital (ROIC)	3.23%	3.23%	-12.90%	-
Return on Capital Employed (ROCE)	6.30%	6.30%	-	-
Earnings Yield	0.22%	0.63%	-12.07%	-6.79%
FCF Yield	-0.02%	-0.06%	-4.91%	-3.77%
Buyback Yield / Dilution	-2.30%	-2.30%	-13.08%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.